Enter the first few characters of Company and click 'Go'
Nine Month Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.(Figures in Rs crores)
|
|
Dec 31, 2023 |
Dec 31, 2022 |
Dec 31, 2021 |
Dec 31, 2020 |
Dec 31, 2019 |
Other Income |
93.61 |
73.55 |
57.28 |
80.58 |
62.40 |
Raw Material |
312.70 |
298.65 |
419.32 |
320.66 |
376.05 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
451.56 |
446.15 |
470.19 |
465.14 |
456.97 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
1,057.52 |
1,058.82 |
958.19 |
1,073.42 |
1,146.69 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
1.03 |
1.16 |
1.72 |
2.90 |
4.83 |
Gross Profit |
737.92 |
705.04 |
637.97 |
603.84 |
541.94 |
Depreciation |
51.58 |
48.59 |
52.84 |
61.43 |
60.09 |
Taxation |
148.72 |
171.86 |
134.76 |
143.99 |
173.98 |
Extra Ordinary Item |
-146.01 |
-8.32 |
22.32 |
-53.60 |
-335.76 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
169.41 |
169.41 |
169.41 |
169.41 |
169.41 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
23.12 |
28.11 |
27.90 |
20.35 |
-1.65 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article